Editors, Publishers, Impact Factors, and Reprint Income
▻https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964337
mise en évidence d’un biais chez les éditeurs de journaux médicaux : ils peuvent accroître leur facteur d’impact (taux de citations) en acceptant les articles sponsorisés par l’industrie pharmaceutique
Journal editors have expended much time and effort in teasing out how to handle authors’ and reviewers’ competing interests. They need now to concentrate on their own and those of their employers, lest we reach the dismal scenario described by Marcia Angell: “it is simply no longer possible to believe much of the clinical research that is published